Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-005401-22Phase 3Active
Phase 3, single-arm trial of aliskiren in hypertension (HTN) and chronic kidney disease (CKD), sponsored by University Medical Center Utrecht. Primary endpoint: Effect of Aliskiren on MSNA. Started Oct 2007; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-005401-22.